Literature DB >> 7520198

Neurotrophic factors: from molecule to man.

R M Lindsay1, S J Wiegand, C A Altar, P S DiStefano.   

Abstract

Recent advances in the understanding of the physiological role of nerve growth factor (NGF) have raised the question of whether neurotrophic factors might have clinical potential in the treatment of neurodegenerative disease or nerve trauma. Although NGF was first characterized as a target-derived survival factor for developing sympathetic and sensory neurons, it is now clear that it plays an important role in the maintenance and regeneration of mature peripheral neurons. However, the highly restricted specificity of NGF for sympathetic neurons, subpopulations of neural-crest-derived sensory neurons, and striatal and basal forebrain cholinergic neurons has, for almost two decades, stimulated the search for other neurotrophic factors that might act on the many classes of neurons that do not respond to NGF. In this article, the biology of the recently discovered NGF-related family of neurotrophic factors and ciliary neurotrophic factor and their receptors are reviewed, especially in the context of the therapeutic potential of these factors in the treatment of neurological disorders of the CNS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520198     DOI: 10.1016/0166-2236(94)90099-x

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  109 in total

1.  Protracted elevation of neuronal nitric oxide synthase immunoreactivity in axotomised adult pudendal motor neurons.

Authors:  A H Pullen; P Humphreys
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

2.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

3.  Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-D-aspartate receptor subunit 1.

Authors:  P C Suen; K Wu; E S Levine; H T Mount; J L Xu; S Y Lin; I B Black
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

4.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.

Authors:  K D Anderson; N Panayotatos; T L Corcoran; R M Lindsay; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 5.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 6.  Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.

Authors:  Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki
Journal:  Neurol Sci       Date:  2010-11-24       Impact factor: 3.307

7.  Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.

Authors:  William Berger; Akhil Mehra; Maryann Lenoci; Thomas J Metzler; Christian Otte; Gary Tarasovsky; Synthia H Mellon; Owen M Wolkowitz; Charles R Marmar; Thomas C Neylan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-07-17       Impact factor: 5.067

8.  Selective neuronal toxicity of cocaine in embryonic mouse brain cocultures.

Authors:  M C Nassogne; P Evrard; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Adult ciliary neurotrophic factor receptors help maintain facial motor neuron choline acetyltransferase expression in vivo following nerve crush.

Authors:  Nancy Lee; Carolyn E Rydyznski; Matthew S Rasch; Dennis S Trinh; A John MacLennan
Journal:  J Comp Neurol       Date:  2016-11-07       Impact factor: 3.215

10.  Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.

Authors:  Umut Arslan; Emin Özmert; Sibel Demirel; Firdevs Örnek; Figen Şermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-15       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.